Home Newsfeeds MoneyLion Sees FY22 Adj. Revenue $320M-$330M Vs $331.35M Est

MoneyLion Sees FY22 Adj. Revenue $320M-$330M Vs $331.35M Est

-SEC Filing

byBenzinga Newsdesk

December 8, 2022

1 minute read

-SEC Filing

GSK Says Its Blockbuster Shingles Vaccine Shows High Efficacy Even After 10 Years

By Vandana Singh

April 17, 8:06 AM

Lasting protection against shingles for adults over 50 with GSK's RZV vaccine. New data from ZOSTER-049 trial reveals over a decade of high efficacy. Plus, GSK's oral antibiotic, gepotidacin, shows promising results for uncomplicated gonorrhea treatment.

GSK

Pinduoduo’s Debt Overview

By Benzinga Insights

January 3, 4:12 PM

Shares of Pinduoduo Inc. (NASDAQ:PDD) rose by 33.35% in the past three months. Before having a look at the importance of debt, let's look at how much debt Pinduoduo has.

PDD

‘Nio Plans Europe Expansion As China’s EV Price War Intensifies’- BNN Bloomberg

By Happy Mohamed

April 18, 12:16 AM

https://www.bnnbloomberg.ca/nio-plans-europe-expansion-as-china-s-ev-price-war-intensifies-1.1908854 Electric-vehicle maker Nio Inc. plans to intensify its European expansion as a price war in the company’s

NIO

Dutch Health Tech Firm Philips Stops US Sales Of Respiratory Devices Under Finalized Consent Decree Over Device Recall

By Vandana Singh

January 29, 8:48 AM

Philips' Q4 earnings and FDA settlement insights. Learn about the consent decree, actions, future plans for Philips Respironics in the U.S. International services remain unaffected. Philips' 2024 forecasts and financial outlook.

PHG

MoneyLion Sees FY22 Adj. Revenue $320M-$330M Vs $331.35M Est

Related Posts

GSK Says Its Blockbuster Shingles Vaccine Shows High Efficacy Even After 10 Years

Pinduoduo’s Debt Overview

‘Nio Plans Europe Expansion As China’s EV Price War Intensifies’- BNN Bloomberg

Dutch Health Tech Firm Philips Stops US Sales Of Respiratory Devices Under Finalized Consent Decree Over Device Recall